Using RapidAI data, research in the New England Journal of Medicine has quantified a negative trend in patients seeking stroke care during COVID-19 pandemic.
RapidAI™ empowers clinicians to make faster, more accurate diagnostic and treatment decisions for stroke patients using clinically proven, data-driven technology. With our validated, trusted platform developed by stroke experts, clinicians worldwide are improving patient care and outcomes every day.
The latest automated tools to improve stroke care. Whether detecting intracranial hemorrhage, early ischemic change, thrombosis location or low ADC values, get reliable results anytime, anywhere.
Initially validated by an NIH-sponsored DEFUSE 2 study published in 2012, and further studied by numerous worldwide trials, RapidAI continues to show evidence of success, ultimately helping healthcare professionals save lives.
“...Rapid is unparalleled in ease of implementation and use. RAPID elevates perfusion imaging in the management of acute ischemic stroke.”
“...As a high volume center, Rapid has become an essential tool in our treatment of acute stroke. Its speed, ease of use, and accuracy assessing ischemic penumbra make it far superior to all other methods of acute stroke imaging.”
“...Rapid...shifts our 'speed to decision' to less than two minutes and is accessible 24/7/365.”